http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105434335-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 |
filingDate | 2016-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105434335-B |
titleOfInvention | A kind of liensinine suppository and its preparation method and application |
abstract | The present invention provides a kind of liensinine rectal administration, preparation method and use.The liensinine fat suppository of the present invention includes liensinine, fat-soluble suppository matrix and surfactant, and present invention also offers the purposes of liensinine suppository of the invention in anti-arrhythmia cordis or drug for hypertension is used to prepare.Liensinine rectal administration provided by the invention can avoid liensinine oral absorption bad; seriously caused bioavilability is low for liver first-pass effect; medicine passes through inferior rectal veins and anal veins; enter Inferior vena cava through bone internal jugular vein around liver; and enter systemic circulation, so as to play anti-arrhythmia or antihypertensive function. |
priorityDate | 2016-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.